Papers:
Patient-Centric Dose Equivalency Pilot Study of Incobotulinumtoxin A (Xeomin) Vs. Abobotulinumtoxin A (Dysport) in the Treatment of Glabellar Frown Lines
Patient-Centric Dose Equivalency Pilot Study of Incobotulinumtoxin A (Xeomin) Vs. Abobotulinumtoxin A (Dysport) in the Treatment of Glabellar Frown Lines